lithium orotate: Clinical Trials

2 trials of lithium orotate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow lithium orotate: new trials by email Literature Review of lithium orotate trials Research Report on lithium orotate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response
Lithium orotate, Matched Placebo (Capsules) - Alzheimer s Disease
Phase 1 / Phase 2Not yet recruitingJohns Hopkins University402026-12-012026-10-07
Lithium Dosing Study
Lithium Orotate (LiO), Placebo - Cognitive Impairment, Dementia
Not applicableNot yet recruitingMassachusetts General Hospital2502026-11-162026-11-16

Conditions studied

Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)

Sponsors

Johns Hopkins University (1)  ·  Massachusetts General Hospital (1)

Countries

United States (1)

Top investigators

Christopher Morrow, MD, MHS (1)  ·  Olivia I Okereke, PhD (1)